Indegene (INDGN) | Stock Overview & Key Data
Indegene Performance Comparison
Stock Range
Today's Range
Low: ₹569.00
High: ₹585.75
on October 6, 2025
52 Week Range
Low: ₹499.00
High: ₹735.00
on February 28, 2025
on November 8, 2024
All-Time High: ₹736.30 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR139.2B
EPS
18.09
P/E Ratio (TTM)
32.05
Forward P/E
25.05
P/B Ratio
5.32
PEG Ratio
1.14
Div. Yield
0.34%
ROE
15.55%
Beta
N/A
Debt to Equity
3.88
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
17.57%
Profit Margin
14.89%
Returns and Earnings
Return on Assets (TTM)
12.23%
Return on Equity (TTM)
15.55%
EBITDA
INR6.7B
Net Income (TTM)
INR4.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR121.81
Quarterly Revenue Growth (YoY)
12.50%
Quarterly Earnings Growth (YoY)
32.70%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
0.34%
3-Year Average Dividend Yield
0.34%
3-Year Average Annual Dividend
₹0.67
3-Year Total Dividends
₹2.00
Ex-Dividend Date
June 13, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Indegene INDGN | 139.18B Mid-cap | -0.19% | 3.32% | 0.66% | 7.32% | -5.75% | -16.94% | 3.05% | 3.05% |
| Inventurus Knowledge IKS | 258.45B Large-cap | 2.96% | -1.78% | -1.21% | 14.73% | -20.33% | -17.90% | -17.90% | -17.90% |
| Sagility India SAGILITY | 205.69B Large-cap | 2.82% | 5.16% | 6.76% | 14.90% | -7.78% | 55.00% | 55.00% | 55.00% |
| JSW Steel JSTL | 622.75M Small-cap | 15.98% | 2.16% | -6.82% | -6.33% | -19.64% | -27.86% | -38.01% | 55.45% |
| Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 4.12% | 4.66% | -1.50% | -0.70% | -12.45% | -13.00% | 69.49% | 239.84% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | 2.26% | -3.33% | -15.42% | 10.79% | -4.06% | -5.14% | 63.08% | 80.80% |
Ownership & Short Interest
Insider Ownership
56.76%
Institutional Ownership
17.32%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
273K
Average 90-Day Volume
311K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INDGN's 52-week high and low?
- In the last 52 weeks, Indegene reached a high of ₹735.00 (on November 8, 2024) and a low of ₹499.00 (on February 28, 2025).
- What is the market cap and P/E ratio for INDGN?
- Curious about Indegene's size and valuation? Its market capitalization stands at 139.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.05, and the forward P/E (looking ahead) is 25.05.
- Does INDGN pay dividends? If so, what's the yield?
- Yes, Indegene is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.34%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Indegene's main competitors or similar companies to consider before investing?
When looking at Indegene, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Inventurus Knowledge
IKS258.45B Healthcare Health Information Services -17.90% -17.90% Sagility India
SAGILITY205.69B Healthcare Health Information Services 55.00% 55.00% JSW Steel
JSTL622.75M Healthcare Health Information Services -27.86% -38.01% Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -13.00% 69.49% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic -5.14% 63.08% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indegene Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Indegene's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.55%, the Debt to Equity ratio from the most recent quarter is 3.88, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for INDGN?
- Looking at Indegene's growth, its revenue over the trailing twelve months (TTM) was INR29B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.50%, and quarterly earnings saw a YoY growth of 32.70%.
- How much of INDGN stock is held by insiders and institutions?
- Wondering who owns Indegene stock? Company insiders (like executives and directors) hold about 56.76% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.32%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.